Literature DB >> 29168432

Bayesian latent time joint mixed effect models for multicohort longitudinal data.

Dan Li1, Samuel Iddi1,2, Wesley K Thompson3, Michael C Donohue1.   

Abstract

Characterization of long-term disease dynamics, from disease-free to end-stage, is integral to understanding the course of neurodegenerative diseases such as Parkinson's and Alzheimer's, and ultimately, how best to intervene. Natural history studies typically recruit multiple cohorts at different stages of disease and follow them longitudinally for a relatively short period of time. We propose a latent time joint mixed effects model to characterize long-term disease dynamics using this short-term data. Markov chain Monte Carlo methods are proposed for estimation, model selection, and inference. We apply the model to detailed simulation studies and data from the Alzheimer's Disease Neuroimaging Initiative.

Entities:  

Keywords:  Hierarchical Bayesian models; joint mixed effects models; latent time shift; multicohort longitudinal data

Mesh:

Year:  2017        PMID: 29168432     DOI: 10.1177/0962280217737566

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  14 in total

1.  Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data.

Authors:  Clément Abi Nader; Nicholas Ayache; Giovanni B Frisoni; Philippe Robert; Marco Lorenzi
Journal:  Brain Commun       Date:  2021-04-28

2.  Disease progression models for dominantly-inherited Alzheimer's disease.

Authors:  Dan Li; Michael C Donohue
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

3.  A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation.

Authors:  Joseph Giorgio; William J Jagust; Suzanne Baker; Susan M Landau; Peter Tino; Zoe Kourtzi
Journal:  Nat Commun       Date:  2022-04-07       Impact factor: 17.694

Review 4.  [Machine learning in radiology : Terminology from individual timepoint to trajectory].

Authors:  Georg Langs; Ulrike Attenberger; Roxane Licandro; Johannes Hofmanninger; Matthias Perkonigg; Mario Zusag; Sebastian Röhrich; Daniel Sobotka; Helmut Prosch
Journal:  Radiologe       Date:  2020-01       Impact factor: 0.635

5.  Robust parametric modeling of Alzheimer's disease progression.

Authors:  Mostafa Mehdipour Ghazi; Mads Nielsen; Akshay Pai; Marc Modat; M Jorge Cardoso; Sébastien Ourselin; Lauge Sørensen
Journal:  Neuroimage       Date:  2020-10-16       Impact factor: 7.400

6.  Predicting the course of Alzheimer's progression.

Authors:  Samuel Iddi; Dan Li; Paul S Aisen; Michael S Rafii; Wesley K Thompson; Michael C Donohue
Journal:  Brain Inform       Date:  2019-06-28

7.  Predicting time to dementia using a quantitative template of disease progression.

Authors:  Murat Bilgel; Bruno M Jedynak
Journal:  Alzheimers Dement (Amst)       Date:  2019-02-28

8.  Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Dan Li; Samuel Iddi; Wesley K Thompson; Michael S Rafii; Paul S Aisen; Michael C Donohue
Journal:  Alzheimers Dement (Amst)       Date:  2018-08-29

9.  The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease.

Authors:  Christoforos Hadjichrysanthou; Stephanie Evans; Sumali Bajaj; Loizos C Siakallis; Kevin McRae-McKee; Frank de Wolf; Roy M Anderson
Journal:  Alzheimers Res Ther       Date:  2020-06-13       Impact factor: 6.982

10.  Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention.

Authors:  Philip S Insel; Elizabeth C Mormino; Paul S Aisen; Wesley K Thompson; Michael C Donohue
Journal:  Brain Commun       Date:  2020-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.